Population Pharmacokinetics of Intravenous Linezolid in Premature Infants.


BACKGROUND The emergence of coagulase-negative staphylococci (CoNS) with reduced vancomycin-susceptibility in some neonatal intensive care units (NICU) has resulted in an increase of linezolid use. Linezolid pharmacokinetics (PK) and safety in premature infants still need to be better established. METHODS This was a retrospective PK study. All infants who… (More)
DOI: 10.1097/INF.0000000000002067


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.